Similarly, in Duchenne muscular dystrophy, a variety of CRISPR-based methods have successfully restored dystrophin expression in iPSC models which was subsequently confirmed in murine and larger mammal models with current research focusing on clinical translation (Young et al., 2016; Mollanoori et al., 2020). This evidence concerns the gene DMD and Duchenne muscular dystrophy.